Description
FISH (Fluorescence In Situ Hybridization) testing for Chronic Lymphocytic Leukemia (CLL) uses specific DNA probes to identify chromosomal abnormalities, including deletions of chromosomes 13q and 17p (TP53), deletions of 11q (ATM), and trisomy 12. These abnormalities are important prognostic markers in CLL, influencing disease progression and treatment response.



Reviews
There are no reviews yet.